October 6, 2022 —  Stroke is the leading cause of age-related motor disabilities and is becoming more prevalent in younger populations as well.

October 6, 2022 —  Findings from a Cleveland Clinic-led trial show that increasing the salt intake by mouth for patients who are hospitalized with heart failure

October 5, 2022 —  CinCor Pharma, Inc. (NASDAQ: CINC) today announced that the company will present Phase 2 data from its BrigHtn trial evaluating baxdrostat in patients with treatment-resistant hypertension as part of the late-breaking science session at the upcoming 2022 American Heart Association (AHA) Scientific Sessions taking place November 5-7, 2022, virtually and in Chicago, Illinois.

October 5, 2022 —  University Hospitals (UH) Harrington Heart & Vascular Institute has a rich history of providing the highest level of care for patients.

October 5, 2022 — New data presented at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2022, held Sept. 30-Oct. 3 in Washington, DC, shed light on the impact of an FDA-cleared blood volume analysis test to benefit patients with heart failure.

October 4, 2022 — Newswise — Daxor Corporation, a global leader in blood volume measurement technology, today announces new data validating the benefits of the Company’s BVA-100 diagnostic blood test in reducing hospital length of stay (LOS) for heart failure (HF) pati

October 4, 2022 — The American Heart Association (AHA) Scientific Sessions 2022 is set for November 5-7 at McCormick Place in Chicago, and virtually. On November 4, a Pre-session Symposia and Early Career Day will take place.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now